Disease	Score

Substances	Interaction	Organism	Category

Substances	Interaction	Organism	Category

     bladder cancer Somatic mutations of the TSC1 gene that occur in bladder cells are associated with some cases of bladder cancer. In some of these cells, one copy of the TSC1 gene is missing because the region of chromosome 9 containing the gene has been deleted; the other copy of the gene has a mutation that interferes with its function. As a result, little or no hamartin is produced. A loss of hamartin in bladder cells may allow these cells to grow and divide without control, leading to the formation of a cancerous tumor. It is unclear why inherited TSC1 gene mutations lead to the noncancerous growths characteristic of tuberous sclerosis complex, while somatic mutations in this gene are associated with the development of cancerous tumors. lymphangioleiomyomatosis Mutations in the TSC1 gene can cause a disorder called lymphangioleiomyomatosis (LAM), although mutations in the TSC2 gene appear to be responsible for most cases of this disorder. This destructive lung disease is caused by the abnormal overgrowth of smooth muscle-like tissue in the lungs. It occurs almost exclusively in women, causing coughing, shortness of breath, chest pain, and lung collapse. LAM can occur alone (isolated or sporadic LAM) or in combination with a condition called tuberous sclerosis complex (described below). Researchers suggest that sporadic LAM can be caused by a random mutation in the TSC1 gene that occurs very early in development. As a result, some of the body's cells have a normal version of the gene, while others have the mutated version. This situation is called mosaicism. When a mutation occurs in the other copy of the TSC1 gene in certain cells during a woman's lifetime (a somatic mutation), she may develop LAM. tuberous sclerosis complex More than 400 mutations in the TSC1 gene have been identified in individuals with tuberous sclerosis complex, a condition characterized by developmental problems and the growth of noncancerous tumors in many parts of the body. Most of these mutations involve either small deletions or insertions of DNA in the TSC1 gene. Some mutations create a premature stop signal in the instructions for making hamartin. People with TSC1-related tuberous sclerosis complex are born with one mutated copy of the TSC1 gene in each cell. This mutation prevents the cell from making functional hamartin from that copy of the gene. However, enough hamartin is usually produced from the other, normal copy of the TSC1 gene to regulate cell growth effectively. For some types of tumors to develop, a second mutation involving the other copy of the gene must occur in certain cells during a person's lifetime. When both copies of the TSC1 gene are mutated in a particular cell, that cell cannot produce any functional hamartin. The loss of this protein allows the cell to grow and divide in an uncontrolled way to form a tumor. A shortage of hamartin also interferes with the normal development of certain cells. In people with TSC1-related tuberous sclerosis complex, a second TSC1 gene mutation typically occurs in multiple cells over an affected person's lifetime. The loss of hamartin in different types of cells disrupts normal development and leads to the growth of tumors in many different organs and tissues. other disorders Inherited mutations in the TSC1 gene can cause a disorder known as focal cortical dysplasia of Taylor balloon cell type. This disorder involves malformations of the cerebrum, the large, frontal part of the brain that is responsible for thinking and learning. Focal cortical dysplasia causes severe recurrent seizures (epilepsy) in affected individuals.

     The TSC1 gene provides instructions for producing a protein called hamartin, whose function is not fully understood. Within cells, hamartin interacts with a protein called tuberin, which is produced from the TSC2 gene. These two proteins help control cell growth and size. Proteins that normally prevent cells from growing and dividing too fast or in an uncontrolled way are known as tumor suppressors. Hamartin and tuberin carry out their tumor suppressor function by interacting with and regulating a wide variety of other proteins.

Condition	Change (log2fold)	Comparison	Species	Experimental variables	Experiment name

Condition	Change (log2fold)	Comparison	Species	Experimental variables	Experiment name

The following transcription factors affect gene expression:

• HNF-4alpha1
• HNF-4alpha2
• NF-1

Tissue specificity:

Highly expressed in skeletal muscle, followed by heart, brain, placenta, pancreas, lung, liver and kidney. Also expressed in embryonic kidney cells.

Molecular Function:

• Chaperone Binding
• Gtpase Regulator Activity
• Protein N-Terminus Binding

Biological Processes:

• Activation Of Gtpase Activity
• Adaptive Immune Response
• Adult Locomotory Behavior
• Cardiac Muscle Cell Differentiation
• Cell Cycle Arrest
• Cell-Matrix Adhesion
• Cell Projection Organization
• Cellular Response To Oxygen-Glucose Deprivation
• Cerebral Cortex Development
• Glucose Import
• Hippocampus Development
• Kidney Development
• Memory T Cell Differentiation
• Myelination
• Negative Regulation Of Cell Proliferation
• Negative Regulation Of Cell Size
• Negative Regulation Of Insulin Receptor Signaling Pathway
• Negative Regulation Of Macroautophagy
• Negative Regulation Of Tor Signaling
• Negative Regulation Of Translation
• Neural Tube Closure
• Positive Regulation Of Focal Adhesion Assembly
• Potassium Ion Transport
• Protein Heterooligomerization
• Protein Stabilization
• Regulation Of Cell Cycle
• Regulation Of Cell-Matrix Adhesion
• Regulation Of Neuron Death
• Regulation Of Phosphoprotein Phosphatase Activity
• Regulation Of Protein Kinase Activity
• Regulation Of Stress Fiber Assembly
• Regulation Of Translation
• Response To Insulin
• Rrna Export From Nucleus
• Synapse Organization

*synonyms